Las Vegas, NV -- (SBWIRE) -- 01/22/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: J.C. Penney Company, Inc.(NYSE:JCP), Cell Therapeutics Inc(NASDAQ:CTIC), Galena Biopharma Inc(NASDAQ:GALE), NII Holdings Inc(NASDAQ:NIHD)
J.C. Penney Company, Inc.(NYSE:JCP) was a volume gainer of 27.25 million shares and the average volume of the stock remained 28.65 million shares. The stock opened the session at $6.60 and finished at the end of the day at $6.49 and the stock plunged -0.46%.The market capitalization of the stock remained 1.98 billion. J. C. Penney Company, Inc., through its subsidiary, J. C. Penney Corporation, Inc., operates department stores. The company sells family apparel and footwear, accessories, fine and fashion jewelry, beauty products, and home furnishings. The company was founded in 1902 and is based in Plano, Texas.
Has JCP Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, Cell Therapeutics Inc(NASDAQ:CTIC) exchanged 24.19 million shares and the average volume remained 4.39 million shares. The stock closed the session at $4.21 with the gain of 15.66%. Cell Therapeutics, Inc. acquires, develops, and commercializes treatments for cancer. The company primary focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, Cell Therapeutics, Inc. was founded in 1991 and is headquartered in Seattle, Washington.s
Will CTIC Continue To Move Higher? Find Out Here
Galena Biopharma Inc(NASDAQ:GALE) decreased -8.86% and its closing price was $6.38. The volume of the stock was 20.09 million shares and the average volume remained 7.86 million shares. The market capitalization of the stock remained 671.41 million. The beta of the stock remained 1.11. Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Galena Biopharma, Inc. in September 2011.
Will GALE Get Buyers Even After The Recent Rally? Find Out Here
NII Holdings Inc(NASDAQ:NIHD) exchanged 18.95 million shares in the previous trading session, and its average trading remained 7.10 million shares. NIHD advanced 4.66% and it closed the trading at $3.12. The market capitalization of the stock remained 538.01 million. NII Holdings, Inc., through its subsidiaries, provides wireless communication services under the Nextel brand name to businesses and individuals in Mexico, Brazil, Argentina, Peru, and Chile.
For How Long NIHD’s Gloss will Attract Investors? Find out via this report
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)